Clinical Trial: A Study to Investigate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-risk Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: Respiratory Syncytial Virus
Study Type: INTERVENTIONAL
Official Title: A Phase 3 Study to Evaluate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-Risk Adults
Brief Summary:
The study is divided into 2 parts (Part A and Part B).Part A of the study will evaluate the safety and immune response to mRNA-1345 in high-risk adults aged ?18 to <60 years.Part B of the study will evaluate the safety and immune response to mRNA-1345 in adults who received solid organ transplant (SOT).
Read more